Avalyn Pharma Inc. - 10-Q Filing

Avalyn Pharma Inc. reports Q3 2026 financial results including multi-series preferred stock structures and R&D expense updates.

SEC EDGAR ·

Tickers: $AVLN

Read the full article at SEC EDGAR

More Regulatory news